[HTML][HTML] The effect of biosimilar prescription targets for erythropoiesis-stimulating agents on the prescribing behavior of physicians in Germany

B Birkner, KE Blankart - Value in Health, 2022 - Elsevier
… To observe physician-level prescription behavior, we used national level claims data of SHI
… adjusted their prescribing behavior subject to drug budgets toward a higher share of generic …

Essays on Physician Behavior

S Dykstra - 2020 - search.proquest.com
… , we explore the effects of a prescription drug monitoring program (… of capitation and global
budget contracts that observe … fixed effects at this level rather than physician-level fixed effects

Pharmaceutical opioid marketing and physician prescribing behavior

S Beilfuss, S Linde - Health Economics, 2021 - Wiley Online Library
… This physician-level, publicly available dataset contains information on all Part D final-action
prescription drug … It relies on the fact that drug manufacturers allocate their marketing budget

Essays on Patient Health Insurance Choice and Physician Prescribing Behavior

SN Beilfuss - 2020 - search.proquest.com
… Once the budgets are allocated and pharmaceutical representatives are assigned to their …
Because physicianlevel claims are suppressed if they fall in the interval 1-10, we impute the …

Identifying antibiotic prescribing patterns through multi-level latent profile analyses: a cross-sectional survey of primary care physicians

D Wang, C Liu, X Zhang, C Liu - Frontiers in Pharmacology, 2020 - frontiersin.org
prescriber: average number of medicines per prescription, … method that categorizes
prescribing behaviors using multiple … the seven prescribing indicators at the physician level. LPA …

Physician-level cost control measures and regional variation of biosimilar utilization in Germany

KE Blankart, F Arndt - … Journal of Environmental Research and Public …, 2020 - mdpi.com
drug budget reviews based on their compliance with drug … We analyze physician prescription
behavior in the context of … at the physician level for each quarter between 2009 and 2015. …

“Let the sunshine in”: The impact of industry payment disclosure on physician prescription behavior

T Guo, S Sriram, P Manchanda - Marketing Science, 2020 - pubsonline.informs.org
… driven by local pharmaceutical reps reallocating their marketing budgets across physicians
… Recall that, although we performed the panel regression at the physician level, we consider …

[PDF][PDF] Impact of a detailing restriction policy on prescription behavior

F Gonçalves - core.ac.uk
pharmaceutical industry professionals that helped me generating insights about Pharmaceutical
… ceiling policy has an impact on the prescription behavior of physicians (measured at the …

Impact of a detailing restriction policy on prescription behavior

AJC Valente - 2020 - comum.rcaap.pt
pharmaceutical industry professionals that helped me generating insights about Pharmaceutical
… ceiling policy has an impact on the prescription behavior of physicians (measured at the …

Receipt of promotional payments at the individual and physician network level associated with higher branded antipsychotic prescribing rates

S Hollands - Administration and Policy in Mental Health and Mental …, 2020 - Springer
… influence of pharmaceutical promotion on prescribing behavior is … At the physician level, we
explored both substitution and … Budget-constrained payers such as Medicaid and Medicare …